eCARTv5 Clinical Deterioration Suite (eCART) vs Kantesti AI Blood Test Analyzer

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

eCARTv5 Clinical Deterioration Suite (eCART)

by AgileMD

Kantesti AI Blood Test Analyzer

by PIYA.AI (operating as Kantesti Ltd)

AI Verdict

Tool A, eCARTv5, is designed for continuous, real-time prediction of clinical deterioration in hospitalized patients, integrating with EHRs to provide early warnings and guide care pathways. In contrast, Tool B, Kantesti AI Blood Test Analyzer, focuses on interpreting blood test results for both patients and providers, offering comprehensive reports, trend analysis, and personalized health insights like nutrition plans. While both are AI-powered clinical decision support tools, their distinct applications—in-hospital deterioration prediction versus blood test interpretation—make them adjacent rather than direct competitors.

Choose eCARTv5 Clinical Deterioration Suite (eCART) if…

Choose eCARTv5 Clinical Deterioration Suite if your hospital needs an AI-powered, real-time early warning system to continuously monitor hospitalized adult patients for clinical deterioration. This tool is ideal for critical care, emergency medicine, and hospital medicine departments aiming to proactively identify and manage patients at risk of death or ICU transfer, leveraging embedded clinical pathways for guided care.

View eCARTv5 Clinical Deterioration Suite (eCART) →

Choose Kantesti AI Blood Test Analyzer if…

Choose Kantesti AI Blood Test Analyzer if you require an AI-driven solution for in-depth interpretation of blood test results, offering comprehensive insights for both patients and healthcare providers. This tool is best suited for family medicine, internal medicine, and laboratory medicine practices looking to enhance diagnostic understanding, provide personalized health reports, and offer trend analysis or nutrition recommendations based on a wide range of biomarkers.

View Kantesti AI Blood Test Analyzer →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	Kantesti AI Blood Test Analyzer
Pricing	Contact vendor for tailored quote.	Freemium
Deployment	Cloud-based SaaS, integrated directly into Electronic Health Record (EHR) systems.	Cloud-based
FDA Status	1 AI-estimated	Unknown
Rating	No ratings yet	5.0 (1)

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Kantesti AI Blood Test Analyzer

Kantesti AI Blood Test Analyzer offers a freemium model and is accessible via web, iOS, Android, and Chrome Extension, making it highly accessible to a broad user base, including patients. It emphasizes plain-language explanations and quick analysis (under 60 seconds) of uploaded reports, enhancing ease of use for individuals without medical expertise. AgileMD's eCART, while integrated into EHRs for clinical workflows, is designed for healthcare professionals within a hospital setting, implying a more specialized user base and potentially a steeper learning curve for general users.

Clinical Value

eCARTv5 Clinical Deterioration Suite (eCART)

AgileMD's eCARTv5 is an FDA-cleared Software as a Medical Device (SaMD) that continuously assesses and predicts the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways. This directly impacts critical patient outcomes and care management within a hospital setting. Kantesti AI Blood Test Analyzer provides interpretation of blood test results and health insights, which is valuable for patient education and provider support, but it explicitly states it does not diagnose, treat, or replace a clinician, and its regulatory classification is under review.

Pricing & Value

Kantesti AI Blood Test Analyzer

Kantesti AI Blood Test Analyzer offers a freemium model with transparent pricing tiers starting from u20ac4.99, making it accessible for individual users and providing clear value propositions for different levels of access. AgileMD's eCART requires contacting the vendor for a tailored quote, indicating a higher-cost, enterprise-focused solution with less pricing transparency for general comparison.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness. AgileMD's eCART is designed for seamless EHR integration, has been deployed in over 400 hospitals, and is SOC-II and HIPAA compliant, indicating robust capabilities for large healthcare systems. Kantesti offers a white-label API for enterprise integration, supports over 1,000 biomarkers and 10,000+ lab formats, and has partnerships with major tech companies, showcasing its scalability and adaptability for various healthcare organizations.

Innovation

Tie

Both tools showcase significant innovation in their respective domains. AgileMD's eCARTv5 utilizes a gradient-boosted machine-learning model for early warning scores, outperforming traditional scores in predicting clinical deterioration. Kantesti AI Blood Test Analyzer employs a 2.78 trillion parameter neural network for highly accurate blood test interpretation and offers features like trend analysis, personalized nutrition plans, and DNA health API integration.

Support & Docs

Kantesti AI Blood Test Analyzer

Kantesti AI Blood Test Analyzer provides comprehensive API documentation with quick-start guides, code examples in multiple languages, and FAQs, catering to developers and enterprise clients. While AgileMD's eCART has extensive publications and research, explicit details about their customer support channels and public-facing documentation for ongoing use are less prominent compared to Kantesti's developer-focused resources.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	Kantesti AI Blood Test Analyzer
Name	eCARTv5 Clinical Deterioration Suite (u201ceCARTu201d)	Kantesti AI Blood Test Analyzer
Company	AgileMD	PIYA.AI (operating as Kantesti Ltd)
Description	FDA-cleared, AI-powered Software as a Medical Device (SaMD) that integrates with EHRs to continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways.	Medical-grade AI analysis and interpretation of blood test results, providing comprehensive reports and insights for both patients and healthcare providers. It utilizes a 2.78 trillion parameter neural network for high accuracy and supports over 1,000 biomarkers and 10,000+ lab formats.
Primary Function	AI-powered clinical deterioration prediction and continuous patient risk assessment (death or ICU transfer).	AI-powered blood test interpretation and comprehensive health insight reports.
Key Features	AI-powered clinical deterioration prediction, Continuous patient risk assessment (death or ICU transfer), EHR integration with real-time data (up to 97 variables), Embedded clinical pathways for care guidance, Early warning system (alerts hours before critical illness), Risk stratification (eCART score and risk designation), Minimizes false alarms and clinician workload, Reporting and benchmarking capabilities.	AI-powered blood test interpretation, Comprehensive health insight reports, Trend analysis & health predictions, Personalized AI nutrition diet plans, Smart supplement recommendations, Support for 1,000+ biomarkers and 10,000+ lab formats, Multilingual support (75+ languages on platform, 100+ via API), White-label API for enterprise integration.

Videos

Demos, reviews, and walkthroughs featuring eCARTv5 Clinical Deterioration Suite (eCART) and Kantesti AI Blood Test Analyzer.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and what is the learning curve for physicians?

eCARTv5 integrates directly into EHR systems, providing continuous patient risk assessment and guiding care with embedded clinical pathways, which suggests a direct workflow fit for hospital-based physicians. Kantesti AI Blood Test Analyzer offers AI analysis and interpretation of blood test results, which would likely fit into a physician's workflow for reviewing lab results and generating patient reports. The learning curve for eCARTv5 may involve understanding the AI-powered predictions and clinical pathways, while Kantesti's learning curve would focus on interpreting its comprehensive reports and insights.

What is the depth of EHR integration for each tool, and what data points do they leverage?

eCARTv5 offers deep EHR integration, leveraging up to 97 variables for real-time data analysis to predict clinical deterioration. Kantesti AI Blood Test Analyzer supports over 1,000 biomarkers and 10,000+ lab formats, suggesting extensive integration capabilities for blood test results, though the specific depth of EHR integration beyond lab data isn't detailed.

What is the accuracy or sensitivity of each tool in its respective domain?

eCARTv5 is designed to predict clinical deterioration (death or ICU transfer) and aims to minimize false alarms and clinician workload, indicating a focus on high accuracy and sensitivity in its predictions. Kantesti AI Blood Test Analyzer utilizes a 2.78 trillion parameter neural network for high accuracy in analyzing and interpreting blood test results.

Which medical specialties are these tools best suited for, and how do they support those specialties?

eCARTv5 is specifically designed for Critical Care, Emergency Medicine, and Hospital Medicine, providing early warning systems and risk stratification for hospitalized adult patients. Kantesti AI Blood Test Analyzer is suited for Family Medicine, Internal Medicine, and Laboratory Medicine, offering comprehensive reports, trend analysis, and personalized health insights based on blood test results.

Beyond HIPAA, what are the key security features or postures of each tool, especially concerning patient data?

Both tools are cloud-based and HIPAA compliant. While specific security features beyond HIPAA are not detailed in the provided information, eCARTv5's continuous patient risk assessment and real-time data processing would necessitate robust data security measures to protect sensitive patient information. Kantesti's handling of extensive biomarker data and personalized health predictions also implies a strong security posture to safeguard patient privacy and data integrity.

What kind of audit-trail features do these tools offer to track AI-driven recommendations or analyses?

eCARTv5 provides reporting and benchmarking capabilities, which would likely include audit trails for its AI-powered clinical deterioration predictions and embedded clinical pathways. Kantesti AI Blood Test Analyzer offers comprehensive health insight reports and trend analysis, suggesting that its AI analysis and interpretations are documented, which could form the basis of an audit trail.

How do these tools support multi-site rollouts, and what considerations should be made for larger healthcare systems?

eCARTv5's cloud-based SaaS deployment and EHR integration suggest it can be scaled for multi-site rollouts within hospital systems, with considerations for integrating into various EHR instances and training staff across different locations. Kantesti AI Blood Test Analyzer's cloud-based deployment and white-label API for enterprise integration indicate strong support for multi-site and enterprise-level rollouts, allowing for customization and integration into diverse healthcare IT environments.